Co-Diagnostics forms CoMira Diagnostics JV with Arabian Eagle in Saudi Arabia

Co-Diagnostics (CODX) has entered into a definitive agreement with Arabian Eagle, a regional manufacturing and distribution company based in the Kingdom of Saudi Arabia, to form a joint venture, CoMira Diagnostics, to research, develop, manufacture, assemble, distribute, and commercialize Co-Dx technologies and intellectual property, including the company’s upcoming Co-Dx PCR point-of-care platform, within KSA and 18 other countries throughout the Middle East and North Africa. The CoMira partners also believe that initially pursuing regulatory clearance with the Saudi Food & Drug Administration will directly facilitate entry into many other countries in the Territory. Arabian Eagle will contribute local operational and customer support, lead the manufacturing facility set-up and regulatory clearance/registration responsibilities, manage other logistics activities and ensure compliance with local industrial and commercial laws in pursuit of the JV’s objectives across the territory. Co-Dx will provide CoMira an exclusive license to use, manufacture, and commercialize the licensed IP, which will include the upcoming Co-Dx PCR platform as well as the company’s existing suite of lab-based PCR diagnostic products.